SenesTech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Joel Fruendt

Chief executive officer

US$458.3k

Total compensation

CEO salary percentage	9.6%
CEO tenure	1.5yrs
CEO ownership	0.02%
Management average tenure	no data
Board average tenure	3.5yrs

Recent management updates

Recent updates

We Think SenesTech (NASDAQ:SNES) Needs To Drive Business Growth Carefully

Aug 24

SenesTech EPS of -$0.56

Nov 11

CEO Compensation Analysis

How has Joel Fruendt's remuneration changed compared to SenesTech's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	-US$8m
Sep 30 2023	n/a	n/a	-US$8m
Jun 30 2023	n/a	n/a	-US$9m
Mar 31 2023	n/a	n/a	-US$9m
Dec 31 2022	US$458k	US$44k	-US$10m

Compensation vs Market: Joel's total compensation ($USD458.33K) is below average for companies of similar size in the US market ($USD667.63K).

Compensation vs Earnings: Insufficient data to compare Joel's compensation with company performance.

CEO

Joel Fruendt (62 yo)

1.5yrs

Tenure

US$458,331

Compensation

Mr. Joel L. Fruendt serves as Chief Executive Officer and Director of SenesTech, Inc. since November 15, 2022. He serves as President at SenesTech, Inc. since December 2022. Most recently he served as Pres...

Board Members

Name	Position	Tenure	Compensation	Ownership
Joel Fruendt	CEO, President & Director	1.5yrs	US$458.33k	0.021% $ 837.3
Anders Field	Advisor	no data	no data	no data
Matthew Szot	Independent Vice-Chairman of the Board	8.4yrs	US$120.00k	0.00039% $ 15.2
Jacob Leach	Independent Director	3.5yrs	US$60.00k	0.012% $ 474.9
Julia Williams	Director Emeritus	3.5yrs	US$49.63k	no data
Bill Calloway	Advisor	no data	no data	no data
Jamie Bechtel	Independent Chairman of the Board & Lead Independent Director	6.3yrs	US$180.70k	0.00023% $ 9.0
Delphine Chiavarini	Independent Director	5.9yrs	US$78.50k	0.00012% $ 4.7
Phil Grandinetti	Independent Director	3.5yrs	US$76.00k	0% $ 0

3.5yrs

Average Tenure

50.5yo

Average Age

Experienced Board: SNES's board of directors are considered experienced (3.5 years average tenure).

SenesTech Management

Management criteria checks 2/4

Key information

Recent management updates

Senestech Names Nicole Williams as Chief Revenue Officer

SenesTech, Inc. Announces Executive Changes

SenesTech Announces Resignation of K.C. Kavanagh as Member of Board of Directors

SenesTech, Inc., Annual General Meeting, Jun 23, 2022

High number of new directors

Independent Director recently bought US$229k worth of stock

Recent updates

Nasdaq Determines SenesTech Eligible for an Additional 180 Calendar Day Period, or Until August 19, 2024, to Regain Compliance with the Minimum Bid Price Requirement

Consensus EPS estimates upgraded to US$0.66 loss

New major risk - Financial position

SenesTech, Inc. to Report Q4, 2023 Results on Feb 21, 2024

SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve Soft Bait to Open Field Agriculture Applications

SenesTech's ContraPest Registered for Use in Puerto Rico to Combat Rat Infestations

SenesTech, Inc. has completed a Follow-on Equity Offering.

New major risk - Financial position

SenesTech, Inc. has completed a Follow-on Equity Offering in the amount of $5 million.

SenesTech Receives a Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

SenesTech, Inc. to Report Q3, 2023 Results on Nov 09, 2023

SenesTech Taking Orders for Evolve™ Soft Bait for Rodent Fertility Control

SenesTech, Inc. Launches Evolve Soft Bait for Rodent Fertility Control

New minor risk - Share price stability

SenesTech Receives Non-Compliance Letter from Nasdaq

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

SenesTech, Inc. to Report Q2, 2023 Results on Aug 10, 2023

SenesTech, Inc. Launches Isolate Bait System for Contrapest

First quarter 2023 earnings: EPS and revenues miss analyst expectations

SenesTech, Inc. to Report Q1, 2023 Results on May 11, 2023

No longer forecast to breakeven

Full year 2022 earnings released: US$0.016 loss per share (vs US$14.78 loss in FY 2021)

Senestech Names Nicole Williams as Chief Revenue Officer

Price target decreased to US$4.00

SenesTech, Inc. Announces Executive Changes

SenesTech, Inc. to Report Q3, 2022 Results on Nov 14, 2022

SenesTech Announces Resignation of K.C. Kavanagh as Member of Board of Directors

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

SenesTech, Inc. to Report Q2, 2022 Results on Aug 11, 2022

SenesTech, Inc. Announces its New Elevate Bait System with ContraPest Now Available in California

SenesTech, Inc. Announces its New Elevate Bait System with ContraPest Available for Sale

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

SenesTech, Inc. to Report Q1, 2022 Results on May 12, 2022

SenesTech, Inc., Annual General Meeting, Jun 23, 2022

Price target decreased to US$4.00

Consensus forecasts updated

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new directors

Third quarter 2021 earnings released: US$0.18 loss per share (vs US$0.56 loss in 3Q 2020)

We Think SenesTech (NASDAQ:SNES) Needs To Drive Business Growth Carefully

Consensus forecasts updated

Independent Director recently bought US$229k worth of stock

Second quarter 2021 earnings released: US$0.14 loss per share (vs US$0.59 loss in 2Q 2020)

First quarter 2021 earnings released: US$0.22 loss per share (vs US$1.70 loss in 1Q 2020)

Forecast to breakeven in 2025

Full year 2020 earnings released: US$2.64 loss per share (vs US$7.69 loss in FY 2019)

SenesTech, Inc. to Report Q4, 2020 Results on Mar 25, 2021

New 90-day high: US$2.28

SenesTech, Inc. announced that it has received $10.000004 million in funding

SenesTech, Inc. announced that it expects to receive $10.000004 million in funding

New 90-day high: US$1.90

Revenue beats expectations, earnings disappoint

Third quarter 2020 earnings released: US$0.56 loss per share

SenesTech, Inc. Restructures Board for Commercial Growth

SenesTech EPS of -$0.56

SenesTech, Inc. to Report Q3, 2020 Results on Nov 11, 2020

New 90-day low: US$1.36

Contrapest® Added to San Francisco Reduced Risk Pesticide List

SenesTech, Inc. Maps Out Plan for Increased Use of ContraPest in Integrated Pest Management in California

New 90-day low - US$1.65

Analysts update estimates

Earnings released

SenesTech, Inc. to Report Q2, 2020 Results on Aug 12, 2020

SenesTech, Inc.(NasdaqCM:SNES) dropped from Russell Microcap Index

CEO Compensation Analysis

CEO

Tenure

Compensation